603233.SS
Price:
$17.78
Market Cap:
$20.13B
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.
Industry
Biotechnology
IPO Date
2017-07-31
Stock Exchange
SHH
Ticker
603233.SS
According to DaShenLin Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 20.67. This represents a change of -33.73% compared to the average of 31.19 of the last 4 quarters.
The mean historical PE Ratio of DaShenLin Pharmaceutical Group Co., Ltd. over the last ten years is 33.93. The current 20.67 PE Ratio has changed 5.99% with respect to the historical average. Over the past ten years (40 quarters), 603233.SS's PE Ratio was at its highest in in the December 2024 quarter at 75.27. The PE Ratio was at its lowest in in the December 2023 quarter at -924.54.
Average
33.93
Median
33.06
Minimum
18.59
Maximum
48.36
Discovering the peaks and valleys of DaShenLin Pharmaceutical Group Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 37.06%
Maximum Annual PE Ratio = 48.36
Minimum Annual Increase = -31.47%
Minimum Annual PE Ratio = 18.59
Year | PE Ratio | Change |
---|---|---|
2024 | 18.59 | -25.05% |
2023 | 24.81 | -31.47% |
2022 | 36.20 | -13.74% |
2021 | 41.96 | -13.23% |
2020 | 48.36 | 20.53% |
2019 | 40.12 | 36.71% |
2018 | 29.35 | -28.44% |
2017 | 41.01 | 37.06% |
2016 | 29.92 | 3.36% |
2015 | 28.95 | -20.33% |
The current PE Ratio of DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
26.53
5-year avg
33.98
10-year avg
33.93
DaShenLin Pharmaceutical Group Co., Ltd.’s PE Ratio is less than Yifeng Pharmacy Chain Co., Ltd. (21.62), greater than Shanghai M&G Stationery Inc. (20.03), less than LBX Pharmacy Chain Joint Stock Company (32.06), greater than Autobio Diagnostics Co., Ltd. (19.81), less than Asymchem Laboratories (Tianjin) Co., Ltd. (29.89),
Company | PE Ratio | Market cap |
---|---|---|
21.62 | $33.85B | |
20.03 | $26.94B | |
32.06 | $14.34B | |
19.81 | $22.47B | |
29.89 | $26.49B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DaShenLin Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like DaShenLin Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is DaShenLin Pharmaceutical Group Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)?
What is the highest PE Ratio for DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)?
What is the 3-year average PE Ratio for DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)?
What is the 5-year average PE Ratio for DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)?
How does the current PE Ratio for DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS) compare to its historical average?